688639 Stock Overview
Engages in the development, production, and sale of amino acids and other organic acids in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 6/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Anhui Huaheng Biotechnology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥30.52 |
| 52 Week High | CN¥90.00 |
| 52 Week Low | CN¥26.11 |
| Beta | -0.016 |
| 1 Month Change | -3.66% |
| 3 Month Change | 3.49% |
| 1 Year Change | -59.86% |
| 3 Year Change | -38.07% |
| 5 Year Change | n/a |
| Change since IPO | 82.04% |
Recent News & Updates
Recent updates
Positive Sentiment Still Eludes Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Following 25% Share Price Slump
Jan 17
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially
Dec 20Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Soars 35% But It's A Story Of Risk Vs Reward
Oct 21Here's Why We Think Anhui Huaheng Biotechnology (SHSE:688639) Is Well Worth Watching
Oct 14Slammed 29% Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Screens Well Here But There Might Be A Catch
Sep 05Anhui Huaheng Biotechnology's (SHSE:688639) Profits Appear To Have Quality Issues
Sep 03Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially
Sep 02Many Would Be Envious Of Anhui Huaheng Biotechnology's (SHSE:688639) Excellent Returns On Capital
Aug 20Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jul 22Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Intrinsic Value Is Potentially 43% Above Its Share Price
Jul 12Is Anhui Huaheng Biotechnology (SHSE:688639) Using Too Much Debt?
Jun 21Take Care Before Jumping Onto Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Even Though It's 27% Cheaper
Jun 05We Ran A Stock Scan For Earnings Growth And Anhui Huaheng Biotechnology (SHSE:688639) Passed With Ease
May 12Earnings Report: Anhui Huaheng Biotechnology Co., Ltd. Missed Revenue Estimates By 37%
Apr 23Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Business Is Trailing The Market But Its Shares Aren't
Mar 18Shareholder Returns
| 688639 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | 0.1% | -3.3% | -1.8% |
| 1Y | -59.9% | 0.5% | 9.6% |
Return vs Industry: 688639 underperformed the CN Chemicals industry which returned 1.5% over the past year.
Return vs Market: 688639 underperformed the CN Market which returned 10.5% over the past year.
Price Volatility
| 688639 volatility | |
|---|---|
| 688639 Average Weekly Movement | 5.7% |
| Chemicals Industry Average Movement | 5.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 9.7% |
| 10% least volatile stocks in CN Market | 3.2% |
Stable Share Price: 688639 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688639's weekly volatility (6%) has been stable over the past year.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 1,691 | Henghua Guo | www.huahengbio.com |
Anhui Huaheng Biotechnology Co., Ltd. engages in the development, production, and sale of amino acids and other organic acids in China and internationally. The company offers inositol, D-calcium pantothenate, L-valine, DL- alanine, L-citrulline, DL-malic acid, L-alanine, D-panthenol, L-citrulline DL-malate, L-malic acid, beta-alanine, a- arbutin, L-arginine, ß-arbutin, L-glycine, L-proline, amino acid concentrate, compound amino acid power, microbial inoculum, compound microbial fertilizer, and water soluble fertilizer products. Its products are used in daily chemical, medicine, health and personal care products, food additives, feeds, animal nutrition, plant nutrition, and functional nutrition.
Anhui Huaheng Biotechnology Co., Ltd. Fundamentals Summary
| 688639 fundamental statistics | |
|---|---|
| Market cap | CN¥6.95b |
| Earnings (TTM) | CN¥199.78m |
| Revenue (TTM) | CN¥2.18b |
34.8x
P/E Ratio3.2x
P/S RatioIs 688639 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688639 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.18b |
| Cost of Revenue | CN¥0 |
| Gross Profit | CN¥2.18b |
| Other Expenses | CN¥1.98b |
| Earnings | CN¥199.78m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Apr 23, 2025
| Earnings per share (EPS) | 0.88 |
| Gross Margin | 100.00% |
| Net Profit Margin | 9.15% |
| Debt/Equity Ratio | 110.1% |
How did 688639 perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield48%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/03 07:38 |
| End of Day Share Price | 2025/04/03 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Anhui Huaheng Biotechnology Co., Ltd. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tianhe Wang | China International Capital Corporation Limited |
| Chao Li | Citic Securities Co., Ltd. |
| Lin Yang | Guosen Securities Co., Ltd. |